Seeds, crop protection products and digital services for ever more sustainable agricultural solutions
The next phase of growth in pharma depends on the industry-oriented workforce, risk investment, academic revamp, and creation of R&D hubs, say experts .
The Indian pharma industry has grown at a compounded growth rate of ~11% in the domestic market and ~16% in exports over the last two decades
In the first quarter of this year, Evonik expects adjusted EBITDA of at least €550 million.
The deal is expected to close in the second half of 2021, subject to regulatory approvals and customary closing conditions
Pharma industry is ready to embrace technology platforms with a keen focus on automation in manufacturing and digital health investment.
The well-prepared staff, proper communication with transporters and awareness among people around the chemical plants a need of the hour.
Penicillamine Tablets USP, 250 mg (RLD: Depen) had estimated annual sales of USD 5 million in the U.S. (IQVIA MAT December 2020).
Bharat Biotech expects to share further details of the trial results as additional data become available.
Merck forecasts organic growth of EBITDA pre in a high single-digit to low teens percentage range in 2021.
Multiple productivity initiatives will increase supply of lactic acid, a nature-based ingredient, for the company's customers in Europe and other regions
The company expects permanent structural savings of $6 billion a year by the end of 2023 versus 2019.
Funds raised from the net proceeds will be used to repay/prepay Rs 556.19 cr of its debt
Continued increases in the cost of key raw materials driven by tight supply and strong demand in APAC led to the rise in price.
The Paris-based biocide company is a manufacturer of specialty fungicides for the packaging industry
This share transfer will see the Mitsui Chemicals Group concentrate its resources on two bases in Japan and Thailand.
AEA has made a number of successful investments in the specialty chemicals sector over the last two decades.
The price increases are due to the rising costs of raw materials.
The transaction, which is subject to regulatory approvals and customary closing conditions, is expected to be completed in 2021. Following completion of the transaction, the business will continue to operate under the PQ brand
With the acquisition of Costa Brazil, Amyris will appoint Francisco Costa as Chief Creative Officer of the company
Subscribe To Our Newsletter & Stay Updated
